4833X 15/1000 (Actoplus met XR 1000 mg / 15 mg)
Generic Name: metformin/pioglitazone
Pill imprint 4833X 15/1000 has been identified as Actoplus met XR 1000 mg / 15 mg.
ActoPlus Met XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met XR 1000 mg / 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 4833X 15/1000 (Actoplus met XR 1000 mg / 15 mg)
Actoplus met XR
- Generic Name:
- metformin/pioglitazone
- Imprint:
-
4833X 15/1000
- Strength:
- 1000 mg / 15 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Takeda Pharmaceuticals America
- National Drug Code (NDC):
- 64764-0510
More resources
Actoplus met XR is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
